Table of Content

1. Executive Summary
   1.1. Global Tuberculosis Diagnostics Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global GDP Growth Outlook
       2.3.2. Global Healthcare Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Product Adoption Analysis
   3.2. Disease Epidemiology
   3.3. Regulatory Landscape
   3.4. Value Chain Analysis
   3.5. Key Deals and Mergers
   3.6. PESTLE Analysis
   3.7. Porter’s Five Force Analysis
4. Global Tuberculosis Diagnostics Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   4.1. Global Tuberculosis Diagnostics Market Outlook: Test Type
       4.1.1. Introduction / Key Findings
       4.1.2. Historical Market Size (US$ Mn) Analysis, By Test Type, 2019 - 2022
       4.1.3. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2023 - 2031
           4.1.3.1. Nucleic Acid Testing
           4.1.3.2. SMEAR Microscopy
           4.1.3.3. Radiography Tests
   4.2. Market Attractiveness Analysis: Test Type
   4.3. Global Tuberculosis Diagnostics Market Outlook: End-user
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Mn) Analysis, By End-user, 2019 - 2022
       4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2023 - 2031
           4.3.3.1. Hospitals & Clinics
           4.3.3.2. Diagnostics Centres
   4.4. Market Attractiveness Analysis: End-user
5. Global Tuberculosis Diagnostics Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2022
   5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Tuberculosis Diagnostics Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   6.1. Key Highlights
   6.2. Pricing Analysis
   6.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
       6.3.1. By Country
       6.3.2. By Product
       6.3.3. By End User
   6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       6.4.1. U.S.
       6.4.2. Canada
   6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 - 2031
       6.5.1. Nucleic Acid Testing
       6.5.2. SMEAR Microscopy
       6.5.3. Radiography Tests
   6.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       6.6.1. Hospitals & Clinics
       6.6.2. Diagnostics Centres
   6.7. Market Attractiveness Analysis
7. Europe Tuberculosis Diagnostics Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   7.1. Key Highlights
   7.2. Pricing Analysis
   7.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
       7.3.1. By Country
       7.3.2. By Product
       7.3.3. By End User
   7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       7.4.1. Germany
       7.4.2. France
       7.4.3. U.K.
       7.4.4. Italy
       7.4.5. Spain
       7.4.6. Russia
       7.4.7. Türkiye
       7.4.8. Rest of Europe
   7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 - 2031
       7.5.1. Nucleic Acid Testing
       7.5.2. SMEAR Microscopy
       7.5.3. Radiography Tests
   7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       7.6.1. Hospitals & Clinics
       7.6.2. Diagnostics Centres
   7.7. Market Attractiveness Analysis
8. East Asia Tuberculosis Diagnostics Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   8.1. Key Highlights
   8.2. Pricing Analysis
   8.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
       8.3.1. By Country
       8.3.2. By Product
       8.3.3. By End User
   8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       8.4.1. China
       8.4.2. Japan
       8.4.3. South Korea
   8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 - 2031
       8.5.1. Nucleic Acid Testing
       8.5.2. SMEAR Microscopy
       8.5.3. Radiography Tests
   8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       8.6.1. Hospitals & Clinics
       8.6.2. Diagnostics Centres
   8.7. Market Attractiveness Analysis
9. South Asia & Oceania Tuberculosis Diagnostics Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   9.1. Key Highlights
   9.2. Pricing Analysis
   9.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
       9.3.1. By Country
       9.3.2. By Product
       9.3.3. By End User
   9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       9.4.1. India
       9.4.2. Southeast Asia
       9.4.3. ANZ
       9.4.4. Rest of South Asia & Oceania
   9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 - 2031
       9.5.1. Nucleic Acid Testing
       9.5.2. SMEAR Microscopy
       9.5.3. Radiography Tests
   9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       9.6.1. Hospitals & Clinics
       9.6.2. Diagnostics Centres
   9.7. Market Attractiveness Analysis
10. Latin America Tuberculosis Diagnostics Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   10.1. Key Highlights
   10.2. Pricing Analysis
   10.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
       10.3.1. By Country
       10.3.2. By Product
       10.3.3. By End User
   10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       10.4.1. Brazil
       10.4.2. Mexico
       10.4.3. Rest of Latin America
   10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 - 2031
       10.5.1. Nucleic Acid Testing
       10.5.2. SMEAR Microscopy
       10.5.3. Radiography Tests
   10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       10.6.1. Hospitals & Clinics
       10.6.2. Diagnostics Centres
   10.7. Market Attractiveness Analysis
11. Middle East & Africa Tuberculosis Diagnostics Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   11.1. Key Highlights
   11.2. Pricing Analysis
   11.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
       11.3.1. By Country
       11.3.2. By Product
       11.3.3. By End User
   11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       11.4.1. GCC Countries
       11.4.2. Egypt
       11.4.3. South Africa
       11.4.4. Northern Africa
       11.4.5. Rest of Middle East & Africa
   11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 - 2031
       11.5.1. Nucleic Acid Testing
       11.5.2. SMEAR Microscopy
       11.5.3. Radiography Tests
   11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       11.6.1. Hospitals & Clinics
       11.6.2. Diagnostics Centres
   11.7. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Abbott
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. QIAGEN
       12.3.3. Thermo Fisher Scientific Inc.
       12.3.4. BD
       12.3.5. F. Hoffmann-La Roche AG
       12.3.6. Hologic, Inc.
       12.3.7. Cepheid
       12.3.8. DiaSorin S.p.A.
       12.3.9. Hain Lifescience GmbH
       12.3.10. Oxford Immunotec
       12.3.11. Others
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations